AKT1 and ovarian carcinoma: Thr21 mutation of AKT1 has also been identified in human breast, lung, and ovarian cancers, as evidenced by data from the COSMIC and Bioportal databases, thus highlighting the potential clinical significance of AKT1 T21 phosphorylation in these cancers.